The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| QUINSTREET INC | COM | 74874Q100 | 1,985 | 270,114 | SH | SOLE | 270,114 | 0 | 0 | ||
| FIDUS INVT CORP | COM | 316500107 | 4,182 | 260,105 | SH | SOLE | 260,105 | 0 | 0 | ||
| TRANSENTERIX INC | COM NEW | 89366M201 | 4,336 | 3,032,625 | SH | SOLE | 3,032,625 | 0 | 0 | ||
| XERIUM TECHNOLOGIES INC | COM NEW | 98416J118 | 88 | 18,606 | SH | SOLE | 18,606 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 1,008 | 56,643 | SH | SOLE | 56,643 | 0 | 0 | ||
| NOVOCURE LTD | ORD SHS | G6674U108 | 32,067 | 1,615,479 | SH | SOLE | 1,615,479 | 0 | 0 | ||
| ATHENE HLDG LTD | CL A | G0684D107 | 79,058 | 1,468,396 | SH | SOLE | 1,468,396 | 0 | 0 | ||
| FIRST DATA CORP NEW | COM CL A | 32008D106 | 28,536 | 1,581,821 | SH | SOLE | 1,581,821 | 0 | 0 | ||